Cure8 research brief
The study reports that Chlorella-derived polysaccharide AHP reduced inflammation, supported barrier repair, and changed gut microbiota in cell and mouse colitis models—suggesting a potential new bioactive candidate for IBD treatment development or functional-food approaches.
Researchers in IBD drug discovery and microbiome science; clinicians and patients interested in experimental nutraceutical approaches (note: evidence is preclinical).
The study used Caco-2 cells (an intestinal epithelial cell line) and DSS-induced colitis in mice to evaluate AHP. In cells, AHP reduced reactive oxygen species, suppressed apoptosis, and lowered pro-inflammatory markers.
In mice, AHP lessened colon pathology, decreased oxidative stress and inflammatory cytokines, improved tight-junction protein expression, and altered gut microbiota and metabolites. The report frames AHP as a promising bioactive substance for further exploration but does not provide clinical data in humans.
Findings are from in vitro and DSS mouse model experiments described in the article abstract. These results are hypothesis-generating; they do not prove benefit or safety in humans and require clinical trials.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declarations. Conflict of interest: The authors declare no competing financial interest. Ethical approval: The entire experimental procedures were strictly conducted in accordance with “Guangxi Normal University Animal Care and Use Committee Guidelines”, and approved by Animal Ethics Committee of Guangxi Normal University. Informed consent: Not applicable.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study identifies a plant-derived compound that reduced inflammation and liver injury in a mouse model of ulcerative colitis and ties its effects to both JAK2/STAT1 inhibition and changes in the gut microbiota—two...
A plant polysaccharide (PVP) reduced inflammation and preserved intestinal barrier proteins in a mouse model of ulcerative colitis, apparently by increasing a specific gut bacterium. This points to a microbiome-related...
The study introduces a colon-targeted EGCG delivery system that reduced inflammation and improved microbial and metabolic markers in a mouse model of UC, suggesting a potential new therapeutic approach worth further...
